BioPioneers ’ Angel & Pre-Seed Playbook was a masterclass in what actually gets the first check in biotech/techbio: Top takeaways - Scientists often jump to mechanism — investors first need the problem, stakes, and market. - At pre-seed, it’s mostly team + narrative; the seed bar is rising fast (more proof expected). - In TechBio/AI: more data ≠ more value. Show a feedback loop, proprietary/credible biology, and a few sharp use cases. - Fundraising mechanics matter: party rounds scare later...